| Predicted Trait | |
| Reported Trait | Microalbuminuria |
| Mapped Trait(s) | Moderate albuminuria (HP_0012594) |
| Score Construction | |
| PGS Name | mAlb |
| Development Method | |
| Name | Genome-wide significant SNPs |
| Parameters | NR |
| Variants | |
| Original Genome Build | NR |
| Number of Variants | 29 |
| Effect Weight Type | beta |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000623 |
| Citation (link to publication) | Cañadas-Garre M et al. Int J Mol Sci (2023) |
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | European: 100% 155,728 individuals (100%) |
| PGS Evaluation | European: 100% 1 Sample Sets |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
Europe PMC: 26631737 |
67,452 individuals | European | ADVANCE_TRIAL |
Europe PMC: 21355061 |
63,153 individuals | European | CARDIA, CKDGen, MESA |
Europe PMC: 31537649 |
19,406 individuals | European | 14 cohorts
|
GWAS Catalog: GCST005895 Europe PMC: 29703844 |
5,717 individuals | European | NR |
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM021277 | PSS011675| European Ancestry| 389,206 individuals |
PGP000623 | Cañadas-Garre M et al. Int J Mol Sci (2023) |
Reported Trait: Microalbuminuria | OR: 1.014 [1.001, 1.027] | — | R²: 0.015 | Age, sex, BMI, anti-hypertensive medication, cholesterol medication, diabetes, smoking history, insulin | — |
| PPM021280 | PSS011675| European Ancestry| 389,206 individuals |
PGP000623 | Cañadas-Garre M et al. Int J Mol Sci (2023) |
Reported Trait: Urinary albumin-to-creatinine ratio | β: 0.005 (0.002) | — | R²: 0.093 | Age, sex, BMI, anti-hypertensive medication, cholesterol medication, diabetes, smoking history, insulin | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS011675 | — | — | 389,206 individuals, 46.1 % Male samples |
Mean = 56.9 years Sd = 8.0 years |
European | — | UKB | — |